Peripheral arterial disease (PAD) is an important public health problem which affects approximately 8.5 million people over the age of 40 in the United States [1] and 202 million people globally. [2] Prevalence of PAD rises drastically with age and affects a great quantity of the elderly population. [3] In China, the prevalence of PAD was 6% in people over 35 years of age, 15% in people over 60 years of age, and even higher in those with diabetes mellitus, coronary heart disease, etc. [4] PAD is also correlated to a high risk of fatal and nonfatal cardiovascular events, and is the third leading cause of atherosclerotic vascular morbidity after coronary heart disease and stroke; thus, PAD bears a heavy burden on public health worldwide. [5] PAD comprises a range of noncoronary arterial syndromes such as lower extremity arterial disease, mesenteric arterial disease, and renal arterial disease because the altered structure and function of the noncoronary arteries contribute to their cause. The high morbidity and mortality of PAD have aroused the attention of researchers who have discovered many pathophysiological processes are involved in the process of arterial stenosis, while atherosclerosis most commonly affects large and medium arteries. [6] During their investigation, researchers have proved that inflammation acts as a central role in the development and progression of systemic atherosclerosis. [7] Therefore, it is assumed that inflammation is associated with PAD. Many inflammatory markers, such as C-reactive protein (CRP) and interleukin-6 (IL-6), have been increasingly examined as potential risk factors for PAD.
Furthermore, WBC count can also predict all-cause mortality in patients referred to the noninvasive vascular laboratory, including those subsequently confirmed to have PAD. [12] To the best of our knowledge, there has been no large-scale study on the association between WBC count and PAD in the Chinese population. Therefore, we aim to investigate the association between WBC count and the prevalence of PAD in a Chinese community-based population in this cross-sectional study.
MateRials and Methods
A total of 9540 Chinese participants from an atherosclerosis cohort with ages ≥40 years and without fever were included in our cross-sectional study. [13] Among them, 37 participants without WBC count and 389 participants without ankle-brachial index (ABI) were excluded from the study. We also excluded two participants with an ABI ≥1.4 due to noncompressible vessels. Thus, there were 9113 participants that remained in the analysis. This study was approved by the Ethics Committee of Peking University First Hospital and Peking University, and each participant provided written informed consent.
Cardiovascular risk factors, comorbidities, and medications
Demographic information, lifestyle, and medical histories such as age, gender, smoking and drinking status, history of cardiovascular disease, and medications (antihypertensive agents, lipid-lowering agents, and hypoglycemic agents) were extracted from a standard questionnaire. Body mass index (BMI) was calculated using the following formula "weight (kg)/height (m)." Current smoking was defined as smoking 1 cigarette per day for at least half a year. Current drinking was defined as drinking once per week for at least half a year. Hypertension was defined as a blood pressure of 140/90 mmHg, a reported history of hypertension, or taking anti-hypertensive drugs. Dyslipidemia was defined as total cholesterol >5.18 mmol/L. Triglycerides 1.7 mmol/L or low-density lipoprotein -cholesterol >3.37 mmol/L, high-density lipoprotein-cholesterol <1.04 mmol/L, or taking lipid-lowering agents. Diabetes mellitus was defined as any self-reported history of diabetes mellitus, a fasting blood glucose level ≥7.0 mmol/L, an oral glucose tolerance test ≥11. 1 mmol/L, or taking hypoglycemic drugs. Cardiovascular disease was defined as any self-reported history of coronary artery disease, stroke, or transient ischemic attack.
Major indexes
Samples of blood were obtained after fasting for at least 12 h. WBC and its differentiation were measured automatically by a Mindray BC 3000 hematology analyzer (Mindray Medical International, Inc.).
ABI was measured using a BP-203RPEIII machine (Omron Healthcare, Inc.) after remaining in a supine position for at least 5 min. ABI value was yielded automatically after waveform detection at the same time of limb blood pressure measurement. PAD was defined as at least one side ABI value <0.9.
[6]
Statistical analysis
Continuous variables were reported as the mean ± standard deviation (SD). Categorical variables were presented as n (%). Normally distributed continuous variables were compared using a one-way ANOVA. The Pearson Chi-square test was applied to all categorical variables. Kruskal-Wallis test was used to perform the trend test. Spearman correlation coefficient was used to assess the correlations between WBC count and ABI.
Logistic regression model adjusted for major covariates (sex, age, smoking status, drinking status, BMI, hypertension, diabetes mellitus, dyslipidemia, history of cardiovascular disease, anti-hypertensive agents, hypoglycemic agents, and lipid-lowering agents) and was used to investigate WBC count and the prevalence of PAD. Furthermore, we classified the population into four groups according to WBC quartiles and the lowest quartile group was considered as the reference group. The association of WBC and PAD prevalence was then assessed using a logistic regression model.
A two-sided P < 0.05 was deemed statistically significant. All the statistical analyses were performed with Empower (R) (www.empowerstats.com, X and Y solutions, Inc. Boston, MA, USA) and R software (http://www.R-project.org).
Results

Patient characteristics
Baseline characteristics of all participants and of quartiles of WBC count are shown in Table 1 . Participants were 56.98 ± 9.09 years old and 36.2% were male. Among them, 19.0% were current smokers, 23.3% were current drinkers, 49.2% were diagnosed with hypertensive, and 25.2% were diagnosed with diabetic. Participants with higher WBC count were older, predominantly male, and had higher BMI. Furthemore, the prevalence of other risk factors, including current smoking and drinking, hypertension, dyslipidemia, diabetes mellitus, and cardiovascular disease, was higher.
Major indexes
The mean WBC count was (6.07 ± 1.59) × 10 9 /L. Mean ABI value was 1.10 ± 0.09. According to the ABI diagnostic criteria defined, 2.4% of the participants were diagnosed with PAD.
In the logistic regression model, WBC count was significantly associated with PAD prevalence (odds ratio [OR] = 1.25, 95% confidence interval [CI]: 1.16-1.34, P < 0.001) with every 1 × 10 9 /L increase of WBC count. It remained significant after adjustment for age, gender, BMI, current smoking and drinking status, hypertension, diabetes mellitus, dyslipidemia, cardiovascular disease history, anti-hypertensive agents, lipid-lowering agents, and hypoglycemic agents (OR = 1.19, 95% CI: 1.10-1.28, P < 0.001). WBC count within normal range also showed a significant association with PAD prevalence (OR = 1.33, 95% CI: 1.21-1.47, P < 0.001).
After adjustment for the same above factors, the relationship remained statistically significant (OR = 1.26, 95% CI: 1.13-1.40, P < 0.001). We further divided the participants into four groups according to WBC count equally and the categories were presented as follows: Q1 (WBC count ≤4.9 × 10 9 /L), Q2 (WBC count 5.0-5.8 × 10 9 /L), Q3 (WBC count 5.9-6.9 × 10 9 /L), and Q4 group (WBC count ≥7.0 × 10 9 /L). Graded positive association was present between WBC count and ABI value (P < 0.001), represented as 1.30%, 1.60%, 2.40%, and 4.10%, respectively [ Figure 1 ].
As shown in Table 2 , with higher WBC quartile, a higher odds ratio was shown. The top quartile of WBC counts revealed a 3.36-fold increase (OR = 3.36, 95% CI: 2.19-5.14, P < 0.001) in OR compared with the lowest quartile. The relationship remained significant after full adjustment (OR = 2.51, 95% CI: 1.61-3.92, P < 0.001). The third quartile of WBC counts also revealed a 1.98-fold increase compared to the lowest quartile (OR = 1.98, 95% CI: 1.26-3.12, P = 0.003). After full adjustment, the relationship remained significant [OR = 1.66, 95% CI: 1.05-2.64, P = 0.032, Table 2 ].
discussion
The main findings of the present study was that elevated WBC count, independent of traditional cardiovascular risk factors, associated with high PAD prevalence in a Chinese community-based population. To the best of our knowledge, this is the first large-scale cross-sectional study providing data to confirm the association between WBC count and PAD prevalence in the Chinese population.
The concept that atherosclerosis plays a pivotal role in PAD is widely accepted, [14] and data have shown that inflammation involves in the initiation and progress of atherosclerosis. [7, 15] Numerous researchers have proved that inflammatory markers such as CRP, WBC, and IL-6 were independently associated with morbidity and mortality of cerebral vascular disease and coronary artery disease. [16, 17] It is well established that the pathology involved in PAD and other atherosclerotic disease is nearly the same. Furthermore, Rein et al. revealed that inflammatory activity in PAD patients is higher than in coronary artery disease patients. [18] In addition, PAD was found to be associated with increased levels of circulating inflammatory markers including IL-6, IL-1 receptor antagonist, CRP, and fibrinogen.
[19] Thus, we postulate that inflammation is closely related with PAD.
High leukocyte count, a common and well-known indication of inflammation, has long been proved to be associated with increased coronary heart disease-related morbidity and mortality in various patient populations and clinical settings. [17, 20, 21] Similarly, elevated leukocyte levels are also associated with stroke in morbidity, mortality, the severity of manifestations, and prognosis. [22, 23] In the National Health and Nutrition Examination Survey . [11] Individuals with PAD demonstrated a higher level of WBC count compared with those free of PAD in the atherosclerosis risk in communities study cohort. [24] Further supporting their relationship, WBC count was reduced at 1-month follow-up after successful lower extremity angioplasty. [25] Our results are consistent with those of previous studies even after adjusting for these confounding factors. Although WBC count could simply act as a marker of inflammation in the progress of the atherosclerotic vascular disease, it is possible that WBC may have a pathogenic role. It has been proven that WBC may act in coronary heart disease through endothelial cell injury caused by proteolytic enzymes, vessel plugging, decreased perfusion, etc. [20] Leukocytosis may also be due to the presence of inflammation in PAD patients. The possible mechanisms of which elevated WBC count may be associated with PAD prevalence have been reviewed by Coller and showed that WBC was relevant with increased inflammation, endothelial damage, procoagulant effects, and microvascular damage. [26] Moreover, when PAD occurs, repetitious muscle ischemia would produce oxidative stress, which then brings subclinical inflammatory activity. [27] It may also contribute to higher leukocyte level.
The study has several limitations. First, our study is cross-sectional which cannot provide a cause-and-effect relationship between leukocyte count and PAD prevalence. Faisal et al. followed 242 participants for a median of 71 months and found WBC count predicts all-cause mortality in patients with PAD12. Thus, a further prospective study is needed to support our conclusion to determine the causal role of WBC in PAD risk. Second, WBC subtypes could have different roles in PAD pathogenesis. Monocytes were showed to be significantly and independently associated with PAD after adjustment for other inflammatory markers in a cross-sectional study containing 3949 individuals 40 years of age without the known cardiovascular disease who participated in the 1999-2002 National Health and Nutrition Examination Survey. [28] However, differentiation of monocytes is not available in our study, and we could not evaluate this association. Third, WBC count is influenced by various diseases, such as infection and hematological diseases. Due to the lack of specific information, we only excluded participants with a fever which could be a confounding factor. The fact that sensitivity test showed a significant similar relationship in participants within normal WBC range supported our findings.
conclusions
Elevated WBC count independently associates with high PAD prevalence in a Chinese community-based population which supports the hypothesis that systemic inflammation plays an important role in the etiology of the atherosclerotic cardiovascular disease. The assessment of WBC is easily available and inexpensive. Thus routine WBC count measurement could be used in identifying high-risk PAD individuals in areas with less-developed medical care systems without ABI facility.
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